Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2012
09/12/2012EP2497766A1 A crystalline form of bimatoprost, preparation method and use thereof
09/12/2012EP2497484A2 A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
09/12/2012EP2497477A1 Alcoholic extract of fungi of genus Cunninghamella and use thereof
09/12/2012EP2497476A1 Aripiprazole pamoate salt
09/12/2012EP2497475A1 Treatment of laminitis with platelet aggregation inhibitors
09/12/2012EP2497474A1 Compositions and Methods Of Using (R)-Pramipexole
09/12/2012EP2497473A1 Therapeutically effective amounts of R(+) and S(-) pramipexole for use in the treatment of Parkinson's disease and pharmaceutical compositions thereof
09/12/2012EP2497472A1 Therapeutically effective amounts of R(+) and S(-) pramipexole for use in the treatment of Parkinson's disease and their pharmaceutical compositions
09/12/2012EP2497471A2 Use of benzo-heterocycle derivatives for preventing and treating cancer or for inhibiting cancer metastasis
09/12/2012EP2497470A1 Imidazotriazines and imidazopyrimidines as kinase inhibitors
09/12/2012EP2497469A1 Use of danshensu, notoginsenoside r1 or their combination in preparation of medicaments for preventing and treating diseases caused by microcirculation disorder
09/12/2012EP2497468A1 Polyacrylamide hydrogel for use in the treatment and/or prevention of joint swelling and/or bone oedema in a mammal suffering from arthritis
09/12/2012EP2497467A1 Pharmaceutical combinations, pharmaceutical compositions, medicament and method for the treatment of animals
09/12/2012EP2497466A2 Preparation for oral administration
09/12/2012EP2497464A2 Pharmaceutical composition of imatinibe methanesulphonate and a process for its manufacture
09/12/2012EP2497461A2 Paediatric solutions comprising a beta-blocker
09/12/2012EP2497460A1 Methods of reducing microbial contamination
09/12/2012EP2497459A1 Methods of reducing microbial contamination
09/12/2012EP2497458A1 Small molecule modulators of the cold and menthol receptor TRPM8
09/12/2012EP2496700A1 Nucleic acid-containing lipid particles and related methods
09/12/2012EP2496587A1 Composition comprising a phosphate, a phosphonate, a phosphite or a phosphoramidate with polyol substructures
09/12/2012EP2496584A1 Process for the preparation of imidazo[2,1-b][1,3]benzothiazole derivatives
09/12/2012EP2496583A1 Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
09/12/2012EP2496582A1 Benzodiazepine bromodomain inhibitor
09/12/2012EP2496581A1 Condensed azepine derivatives as bromodomain inhibitors
09/12/2012EP2496580A1 Benzodiazepine bromodomain inhibitor
09/12/2012EP2496579A1 1-substituted 2-azabicyclo [3.1.1]heptyl derivatives useful as nicotinic acetylcholine receptor modulators for treating neurologic disorders
09/12/2012EP2496578A2 Imidazo[1,2-a]pyridine compounds, synthesis thereof, and methods of using same
09/12/2012EP2496577A1 Imidazopyridine derivatives
09/12/2012EP2496576A1 Imidazo [4, 5-c]quinoline derivates as bromodomain inhibitors
09/12/2012EP2496575A1 Heterocyclic sulfonamide derivatives useful as mek inhibitors
09/12/2012EP2496574A1 Imidazopyridines as a novel scaffold for multi-targeted kinase inhibition
09/12/2012EP2496572A1 Benzimidazole-imidazole derivatives
09/12/2012EP2496568A1 Polymorph of 3-(substituteddihydroisoindolinone-2-yl)-2,6-dioxopiperidine, and pharmaceutical compositions thereof
09/12/2012EP2496567A2 Novel benzopyran kinase modulators
09/12/2012EP2496566A1 Akt / pkb inhibitors
09/12/2012EP2496563A1 Certain crystalline hydrates, pharmaceutical compositions thereof and methods for preparation and use thereof
09/12/2012EP2496561A1 Process for preparing aminale and their use for preparing 1,3-disubstituted pyrazole compounds
09/12/2012EP2496560A1 Process for preparing 1,3-disubstituted pyrazole compounds
09/12/2012EP2496559A1 Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
09/12/2012EP2496558A1 Thetrahydroquinolines derivatives as bromodomain inhibitors
09/12/2012EP2496557A1 Tetrahydroquinoline derivatives and their pharmaceutical use
09/12/2012EP2496556A1 Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals
09/12/2012EP2496555A1 4r,5s-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity
09/12/2012EP2496553A1 A novel process for the preparation of prostaglandins and intermediates thereof
09/12/2012EP2496268A1 Nanoparticle-based gene delivery systems
09/12/2012EP2496261A2 Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
09/12/2012EP2496246A2 Composition, method, and kit for alpha-1 proteinase inhibitor
09/12/2012EP2496239A2 Copper salts of ion exchange materials for use in the treatment and prevention of infections
09/12/2012EP2496238A1 Lipid formulated compositions and methods for inhibiting expression of transthyretin (ttr)
09/12/2012EP2496237A2 Enzyme inhibiting compounds
09/12/2012EP2496236A1 Prolyl hydroxylase inhibitors
09/12/2012EP2496235A1 Bromodomain inhibitors for treating autoimmune and inflammatory diseases
09/12/2012EP2496234A1 Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors
09/12/2012EP2496233A1 Nutritional supplements for relief of dry eye
09/12/2012EP2496232A1 A method to enhance endurance
09/12/2012EP2496231A1 Tryptophan hydroxylase inhibitors for the treatment of cancer
09/12/2012EP2496230A1 Ire-1 alpha inhibitors
09/12/2012EP2496229A1 Pharmaceuticals containing choline
09/12/2012EP2496228A2 Methods for treating attention-deficit/hyperactivity disorder
09/12/2012EP2496227A2 Methods for treating fibromyalgia syndrome
09/12/2012EP2496226A1 New therapeutic approaches for treating alzheimer disease
09/12/2012EP2496225A1 Sphingosine type 1 inhibitors and methods for making and using same
09/12/2012EP2496224A1 Methods of treating elevations in mtor signaling
09/12/2012EP2496223A2 Pharmaceutical solid dosage form
09/12/2012EP2496222A2 The parmaceutical compositions comprising calcium and vitamin d
09/12/2012EP2496221A2 Multilayer pharmaceutical composition that can be dispersed in water and which contains a combination of antimalarial agents
09/12/2012EP2496220A1 Modified release formulation of lacosamide
09/12/2012EP2496219A1 Pharmaceutical tablet containing a liquid filled capsule
09/12/2012EP2496218A1 Bioequivalent formulation of efavirenz
09/12/2012EP2496217A1 Direct compression tablets of otilonium
09/12/2012EP2496215A2 Antimicrobial and anti-acne formulations
09/12/2012EP2496214A1 Ophthalmic formulations containing substituted gamma lactams and methods for use thereof
09/12/2012EP2496087A1 Process for the preparation of pyrazinone thrombin inhibitor and its intermediates
09/12/2012EP2496086A1 Compounds and methods for kinase modulation, and indications therefor
09/12/2012EP2496084A1 Compositions and methods for treating colitis
09/12/2012EP2496083A1 Nicotine containing formulation
09/12/2012EP2496082A1 Methods for increasing the stabilization of hypoxia inducible factor-1 alpha
09/12/2012EP2496081A1 Ite for cancer intervention and eradication
09/12/2012EP2496080A1 Methods for treating parkinson's disease
09/12/2012EP2496079A1 Novel crystalline forms of (1s,2r)-2-(amino methyl)-n,n-diethyl-1-phenyl cyclopropane carboxamide
09/12/2012EP2368547B1 Antiviral compositions comprising geraniol and carvone
09/12/2012CN1883484B Novel pharmacological use of cucurbitacine
09/12/2012CN102666587A Methods for treatment of muscular dystrophy
09/12/2012CN102666563A Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as A2A R agonists
09/12/2012CN102666562A Novel 3'-deoxy-3'-methylidene- -l-nucleosides
09/12/2012CN102666553A Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
09/12/2012CN102666552A Bicyclic thiazoles as allosteric modulators of mglur5 receptors
09/12/2012CN102666551A Bicyclic thiazoles as allosteric modulators of mglur5 receptors
09/12/2012CN102666550A Spiropiperidine compounds as ORL-1 receptor antagonists
09/12/2012CN102666548A Tricyclic antibiotics
09/12/2012CN102666546A Solid forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide
09/12/2012CN102666545A Heterocyclyl pyrazolopyrimidine analogues as jak inhibitors
09/12/2012CN102666544A Pyrrolo[2,3-d]pyrazin-7-yl pyrimidine compounds
09/12/2012CN102666543A Inhibitors of diacylglycerol acyltransferase
09/12/2012CN102666542A Pyrazolopyrimidine derivatives
09/12/2012CN102666541A Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections
09/12/2012CN102666540A Condensed azine-derivatives for the treatment of diseases related to the acetylcholine receptor
09/12/2012CN102666538A Pyrrolopyridinyl-pyrimidin-2-ylamine derivatives
09/12/2012CN102666537A Azaindazoles to treat flaviviridae virus infection
1 ... 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 ... 7860